Single-agent taxane is useful in palliative chemotherapy for advanced extramammary Paget disease: a case series

Br J Dermatol. 2019 Oct;181(4):831-832. doi: 10.1111/bjd.17922. Epub 2019 Jul 15.

Authors

M Kato¹, K Yoshino¹, T Maeda¹, K Nagai¹, S Oaku¹, A Hiura¹, Y Fujisawa²

Affiliations

¹ Department of Dermatologic Oncology, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.
² Department of Dermatology, University of Tsukuba, Tsukuba, Japan.

PMID: 30920650
DOI: 10.1111/bjd.17922

No abstract available

Publication types

Evaluation Study
Letter

MeSH terms

Administration, Cutaneous
Aged
Aged, 80 and over
Antineoplastic Agents / administration & dosage*
Docetaxel / administration & dosage*
Drug Administration Schedule
Female
Humans
Male
Middle Aged
Neoplasm Staging
Paget Disease, Extramammary / drug therapy*
Paget Disease, Extramammary / mortality
Paget Disease, Extramammary / pathology
Palliative Care / methods*
Progression-Free Survival
Retrospective Studies
Skin Neoplasms / drug therapy*
Skin Neoplasms / mortality
Skin Neoplasms / pathology

Substances

Antineoplastic Agents
Docetaxel